Board Chair
Chris Stoelhorst has held executive director and non-executive director roles across a range of high-tech industries and sectors over a period of more than 25 years.
These roles followed chief executive positions in New Zealand and overseas, typically of proprietary specialised equipment manufacturing-engineering enterprises offering product that saves lives and protects assets. Chris is active in governance, as independent chair of a number of New Zealand fast-growth high-tech exporting companies facing multiple sectors.
Board Member
Brian Russell has 3 decades of experience in global technology commercialisation, venture financing and innovation, with 16 years based in Europe and America. He was the founder and CEO of the venture-backed company Zephyr Technology Corp (acquired by Covidien/Medtronic), a global leader in wearable sensors
Director
Colin Dawson has held a number of senior executive roles in the primary, secondary and tertiary health care sectors and was a founding partner in health consulting and investment banking services firm Medicus Capital. Relevant healthcare roles have included GM Clinical Support Services Health Waikato, CEO of Integrated Care IT company HSAGlobal, CEO of one of NZ’s largest aged care operations and Executive Director – Group Strategy of healthcare REIT.
Colin is actively involved with investment, development and commercial implementation of novel technology companies. He chairs the Boards of Tiro Medical, Upstream Medical Technologies and Ember Wellbeing Trust. He is a Director of The NZ Institute for Minerals to Materials Research and Deputy Chair of the NZ Institute for Plant and Food Research.
He is a graduate of The University of Auckland Business School, an SEP alumnus of the Stanford University Graduate School of Business and a Chartered Fellow of the NZ Institute of Directors.
（transferred from MBI website）
